1-7 of 7
Anne Weigert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax combined with five days of azacitidine for the treatment of previously untreated Acute Myeloid Leukemia (AML): Initial results of the prospective venaza-5S trial

Free
Klaus Metzeler, Jens Przybilla, Anne Weigert, Mathias Hänel, Thomas Illmer, Julia Pross, Alexander Höllein, Martin Schmidt-Hieber, Ullrich Graeven, Tim Sauer, Stefan Neuburger, Katharina S. Götze, Dominic Brauer, Madlen Jentzsch, Christoph Röllig, Dirk Hasenclever, Uwe Platzbecker
Journal: Blood
Blood (2025) 146 (Supplement 1): 46.
https://doi.org/10.1182/blood-2025-46
Published: 2025
Journal Articles

Venetoclax in combination with hypomethylating agents in adult patients with newly diagnosed AML with CBFB::MYH11 or RUNX1::RUNX1T1 fusions: Real-world outcomes based on international registry data

Free
Leo Ruhnke, Christoph Röllig, Lydia Kretschmer, Jan Moritz Middeke, Sylvia Herold, David Poitz, Pau Montesinos, Maria Del Carmen Martinez Chamorro, Josefina Serrano, Joaquín Sánchez-García, Lara María Gómez García, Francisco-Javier Peñalver, Guillermo Quintero, Virginia Abello, Pierre Yves Dumas, Sarah Bertoli, Christian Recher, Arnaud Pigneux, Jenny O'Nions, Hannah Al-Yousuf, Jad Othman, Richard Dillon, Jiri Mayer, Stephane De Botton, Raphael Itzykson, Herve Dombret, Magdalena Czemerska, Agnieszka Wierzbowska, Anne Weigert, Madlen Jentzsch, Uwe Platzbecker, Karsten Spiekermann, Tim Sauer, Carsten Müller-Tidow, Hubert Serve, Claudia Baldus, Martin Bornhäuser, Klaus Metzeler
Journal: Blood
Blood (2025) 146 (Supplement 1): 5230.
https://doi.org/10.1182/blood-2025-5230
Published: 2025
Journal Articles

Impact of Typical and Atypical Complex Karyotype Subgroups on Outcome of AML Patients Undergoing Allogeneic Stem Cell Transplantation

Free
Jule Ussmann, Anne Weigert, Lara Bischof, Dominic Brauer, Donata Backhaus, Claudia Diener, Maximilian Merz, Vladan Vucinic, Klaus H Metzeler, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch
Journal: Blood
Blood (2023) 142 (Supplement 1): 2244.
https://doi.org/10.1182/blood-2023-179713
Published: 2023
Journal Articles

A Novel and Cost-Efficient Measurable Residual Disease (MRD) Detection Assay Using a Single Molecule Molecular Inversion Probe-Based Next Generation Sequencing (NGS) Assay Predicts Overall Survival in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Free
Simon M. Krauß, Tara Holloway, Lara Bischof, Donata Backhaus, Dominic Brauer, Jule Ussmann, Anne Weigert, Georg-Nikolaus Franke, Vladan Vucinic, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch, Klaus H Metzeler
Journal: Blood
Blood (2023) 142 (Supplement 1): 3616.
https://doi.org/10.1182/blood-2023-181728
Published: 2023
Journal Articles

Collections of Autologous Lymphocytes for Treatment with Chimeric Antigen Receptor (CAR) T-Lymphocytes - No Association of Clonal Hematopoiesis (CH) with Manufacturing Success

Free
Simon M. Krauss, Konstantin Weibl, Enrica Bach, Mandy Brückner, Anne Weigert, Theresa Tumewu, Florian Ramdohr, Elena Ruschpler, Gunhild Vogtmann, Sandra Hoffmann, Olaf Penack, Martin Janz, Raymund Buhmann, Reinhard Henschler, Lars Bullinger, Ulrich Keller, Sebastian Schwind, Maximilian Merz, Madlen Jentzsch, Georg-Nikolaus Franke, Marco Herling, Uwe Platzbecker, Klaus H. Metzeler, Vladan Vucinic
Journal: Blood
Blood (2022) 140 (Supplement 1): 7560–7562.
https://doi.org/10.1182/blood-2022-163360
Published: 2022
Journal Articles

Outcomes Following Hypomethylating Agent / Venetoclax Combination-Therapy for MDS or AML Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

Free
Dominic Brauer, Lara Bischof, Jule Ussmann, Donata Backhaus, Georg-Nikolaus Franke, Vladan Vucinic, Marco Herling, Maximilian Merz, Leanthe Braunert, Doreen Hammerschmidt, Alexander Kühnemund, Anne Weigert, Klaus H. Metzeler, Uwe Platzbecker, Madlen Jentzsch, Sebastian Schwind
Journal: Blood
Blood (2022) 140 (Supplement 1): 4808–4809.
https://doi.org/10.1182/blood-2022-163363
Published: 2022
Journal Articles

Molecular Characterization of Clinical Response in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome Patients Treated with Single Agent Emavusertib

Free
Klaus H. Metzeler, Eric S. Winer, Uwe Platzbecker, Amit Verma, Daniel J. DeAngelo, Stefano R. Tarantolo, David A. Sallman, James Dugan, Stefanie Gröpper, Katharina S. Goetze, Chia-Cheng Li, Wanying Zhao, Maureen Lane, Reinhard von Roemeling, Samantha Carlisle, Anne Weigert, Matthias Böhme, Anne Sophie Kubasch, Guillermo Garcia-Manero
Journal: Blood
Blood (2022) 140 (Supplement 1): 9048–9049.
https://doi.org/10.1182/blood-2022-167477
Published: 2022